bioAffinity Technologies Inc.
BIAF | NASDAQ
$8.80
+$1.10 (+14.29%)
Sep 22, 2026, 2:18 PM ET · Market open
Company Profile
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Key Executives
| Name | Position |
|---|---|
| Maria Zannes | Founder, President, Chief Executive Officer & Director |
| James Michael Edwards | Chief Financial Officer |
| Xavier T. Reveles | Chief Operating Officer |
| Dallas J. Coleman | Vice President of sales |
| Gordon Downie | Chief Medical Officer |
| Julie Anne Overton | Director of Communications |
| Steven Girgenti | Founder & Executive Chairman of the Board |
| Timothy Zannes | Executive Vice President, Secretary & General Counsel |
| William Bauta | Chief Science Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 03, 2026 | 8-K | Current Report |
| Sep 03, 2026 | S-3/A | [Amend] Filing |
| Sep 01, 2026 | 8-K | Current Report |
| Aug 27, 2026 | S-3 | Filing |
| Aug 20, 2026 | 8-K | Current Report |
| Aug 18, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | 8-K | Current Report |
| Jul 31, 2026 | 8-K | Current Report |
bioAffinity Technologies Inc.
| Country | United States |
| IPO Date | Aug 31, 2022 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Maria Zannes |
Contact Details
3300 Nacogdoches Road San Antonio,
Texas 78217 United States
Stock Details
| Ticker Symbol | BIAF |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001712762 |
| CUSIP Number | 09076W406 |
| ISIN Number | US09076W4069 |
| SIC Code | 8731 |
Add to Watchlist
Select watchlists to add or remove BIAF